Literature DB >> 2650707

Increased intracellular free calcium and sensitivity to angiotensin II in platelets of preeclamptic women.

H Haller1, T Oeney, U Hauck, A Distler, T Philipp.   

Abstract

Preeclampsia is characterized by a generalized vasoconstriction and increased vascular sensitivity to angiotensin II. Intracellular free calcium, implicated in vascular smooth muscle contraction, has been found to be elevated in platelets of other hypertensive disorders. We therefore measured intracellular free calcium concentrations by using the fluorescent probe quin-2 in platelets of six patients with preeclampsia and compared them to measurements in ten normotensive pregnant women and ten age-matched nonpregnant women. Intracellular free calcium was also determined in the preeclamptic women after delivery. We found that intracellular free calcium was slightly elevated in normal pregnancy (102 +/- 13 nmol/L v 87 +/- 17 nmol/L) but was markedly increased in preeclampsia (138 +/- 13 nmol/L, P less than .05). This increase disappeared six weeks after delivery (84 + 10 nmol/L, P less than .01). To investigate whether the increased intracellular free calcium was related to angiotensin II, the platelets were exposed to thrombin and angiotensin II in vitro. Exposure to thrombin and angiotensin II caused a dose-dependent increase in intracellular free calcium. The intracellular response to thrombin was not significantly different in the three groups. However, stimulation with angiotensin II revealed an increased response in intracellular free calcium in preeclampsia (P less than .05) that disappeared after delivery. Our findings show a sustained increase in platelet intracellular free calcium in preeclampsia and suggest a functional alteration of the angiotensin II receptor in this disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2650707     DOI: 10.1093/ajh/2.4.238

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  9 in total

Review 1.  Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy.

Authors:  J M Moutquin; P R Garner; R F Burrows; E Rey; M E Helewa; I R Lange; S W Rabkin
Journal:  CMAJ       Date:  1997-10-01       Impact factor: 8.262

Review 2.  Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia.

Authors:  Yang Xia; Susan M Ramin; Rodney E Kellems
Journal:  Hypertension       Date:  2007-06-18       Impact factor: 10.190

3.  Modulation of platelet Ca2+ homeostasis by hypertensive plasma factor(s) derived from patients with early-stage renal disease.

Authors:  H Schiffl
Journal:  Klin Wochenschr       Date:  1991-12-11

4.  Renin angiotensin signaling in normal pregnancy and preeclampsia.

Authors:  Roxanna A Irani; Yang Xia
Journal:  Semin Nephrol       Date:  2011-01       Impact factor: 5.299

5.  Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor.

Authors:  G Wallukat; V Homuth; T Fischer; C Lindschau; B Horstkamp; A Jüpner; E Baur; E Nissen; K Vetter; D Neichel; J W Dudenhausen; H Haller; F C Luft
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

Review 6.  The functional role of the renin-angiotensin system in pregnancy and preeclampsia.

Authors:  R A Irani; Y Xia
Journal:  Placenta       Date:  2008-08-08       Impact factor: 3.481

Review 7.  Is preeclampsia an autoimmune disease?

Authors:  Yang Xia; Rodney E Kellems
Journal:  Clin Immunol       Date:  2009-06-05       Impact factor: 3.969

Review 8.  Vascular and cellular calcium in normal and hypertensive pregnancy.

Authors:  Zuzana Adamova; Sifa Ozkan; Raouf A Khalil
Journal:  Curr Clin Pharmacol       Date:  2009-09-01

Review 9.  Pathological AT1R-B2R Protein Aggregation and Preeclampsia.

Authors:  Ursula Quitterer; Said AbdAlla
Journal:  Cells       Date:  2021-10-01       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.